Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of Guillain-Barré syndrome, a rare but potentially dangerous neurological reaction, U.S. health officials said Monday.
The lawsuit — filed by Nassau County, Suffolk County, and the New York attorney general — accuses some of the biggest pharmaceutical companies and distributors of fueling the opioid epidemic. The litigation is the first of its kind in the nation in which a jury rather than a judge will decide the outcome.
The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis.
Mayor Bill de Blasio wants to offer free vaccinations to all tourists at popular attractions.
Advisers to the CDC said Friday that it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.
A man from Edison, New Jersey is fighting for his life after contracting COVID-19 and despite having been vaccinated with the Johnson & Johnson shot.
The death of a woman who received the single-dose Johnson & Johnson vaccine is under investigation by federal health authorities as part of a broader probe into potential "adverse side effects" from the vaccine.
The supply of the Janssen vaccine will fall next week but New York officials don't expect any vaccination appointments to be canceled.
Cuomo, wearing a mask and making a thumb's up gesture with his left hand, received the single-dose Johnson & Johnson/Janssen COVID-19 vaccine in his right arm.
The mayor hopes to get all homebound residents the Johnson & Johnson vaccine within the next seven weeks.
The Diocese of Rockville Centre claims the vaccine is the result of research originally derived from aborted fetal tissue specimens in the 1970s.
New York will launch a pilot program for the Johnson & Johnson's vaccine at Yankee Stadium in the Bronx, the Javits Center in Manhattan, and the state fairgrounds in Syracuse.
Merck will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
Drug-maker Johnson & Johnson says it is temporarily pausing clinical trials of a COVID-19 vaccine due to "an unexplained illness in a study participant."
Janssen Pharmaceutical is planning to recruit about 60,000 participants to test its COVID-19 vaccine.
New Jersey-based Johnson & Johnson says it has an agreement to deliver 100 million doses of an investigational vaccine to fight the coronavirus.
Johnson & Johnson has issued a written warning to users of its Animas OneTouch Ping insulin pump users that a cyber security issue could allow a person to hack into it using its unencrypted radio frequency communication system.
A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson's well-known baby powder and other products containing talcum.